financetom
Business
financetom
/
Business
/
Merck's cholesterol drug meets main goal in late-stage trial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Merck's cholesterol drug meets main goal in late-stage trial
Sep 2, 2025 4:18 AM

Sept 2 (Reuters) - Drugmaker Merck said on

Tuesday its oral drug met the main goal of reducing bad

cholesterol in patients in a late-stage trial.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Top Midday Stories: DoorDash to Acquire SevenRooms, Deliveroo; Palantir Shares Fall Despite Solid Q1
Top Midday Stories: DoorDash to Acquire SevenRooms, Deliveroo; Palantir Shares Fall Despite Solid Q1
May 26, 2025
11:46 AM EDT, 05/06/2025 (MT Newswires) -- All three major US stock indexes were down in late-morning trading Tuesday as the Federal Reserve's rate-setting committee kicked off its two-day meeting with a decision scheduled for Wednesday. The European Union plans to tack on additional tariffs targeting 100 billion euros ($113 billion) worth of US goods if ongoing trade talks fail...
FTX Creditors Sold Potential $500M Anysphere Stake For $200,000 Before Startup's Valuation Tripled
FTX Creditors Sold Potential $500M Anysphere Stake For $200,000 Before Startup's Valuation Tripled
May 26, 2025
A previously overlooked stake once tied to the collapsed crypto exchange FTX may now be worth roughly $500 million, following a sharp rise in valuation at one of Silicon Valley's hottest AI startups. What Happened: Anysphere, the company behind the AI-powered code-writing assistant Cursor, has raised $900 million in new funding, tripling its valuation to $9 billion, Financial Times reported....
Preview: Oms Energy Technologies Inc Set To IPO Tomorrow
Preview: Oms Energy Technologies Inc Set To IPO Tomorrow
May 26, 2025
OMS Energy Technologies Inc IPO will take place May, 07 on the NASDAQ exchange under the ticker OMSE. The company is offering shares at an expected price between $8.00 and $10.00 per share with an insider lock-up period of 180 days ending on November 03, 2025. See also: Benzinga IPO Calendar About OMS Energy Technologies Inc OMS Energy Technologies Inc...
Copyright 2023-2026 - www.financetom.com All Rights Reserved